Education efforts among providers, payer, and patients can help answer the fundamental and important questions raised by the use of real-world data, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Education efforts among providers, payer, and patients can help answer the fundamental and important questions raised by the use of real-world data, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Transcript:
What is the adoption curve like for using real-world data and how do you get more people comfortable with using real-world data?
The idea of using real world data for regulatory purposes is brand new, and like anything brand new, it should be treated and assessed like that. What we see at COTA is that there's certainly a landscape of sponsors, laggards, those in the middle, and the pioneers. The pioneers are adopting real-world data today and considering how do we actually redesign or consider bringing a clinical trial to the FDA or EMA, differently with real-world data. Those sponsors are using considerations like a single arm trial, and using a comparator cohort with real-world data. For those that are in the middle, or the laggards, a lot of the work that we see that needs to be done is frankly, the education because it's something new. So questions that we hear all the time is why isn't this real-world data the same as my clinical trial data? Why isn't data captured in a reliable format? Why aren't the patients the same? How do we create a matching cohort, from our clinical trial data to the real world data? Is the data going to have the relevant endpoints that we need in our clinical trial relative to the real-world? These are really fundamental, important questions. It's not that for those that aren't adopting, they're not thinking through these questions. I think we just need a lot of education work, frankly, across sponsors, regulators, real-world data companies to help answer those questions. That validation work will really help pave the way for how this data can be used.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More